Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes
Jessica W Skelley, Brooke S Carter, Megan Z Roberts Department of Pharmacy Practice, McWhorter School of Pharmacy, Samford University, Birmingham, AL, USA Abstract: Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes mellitus, as well as the leading di...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-12-01
|
| Series: | Vascular Health and Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-potential-of-canagliflozin-in-cardiovascular-risk-reduction-i-peer-reviewed-article-VHRM |